. home.aspx

home.aspx
   

The Enormous Potential of AI for Pharmaceutical

September 18, 2019 / EDWARD FFRENCH AND NNAMDI OKORE-AFFIA

The adoption of Artificial Intelligence (AI) in research-intensive organizations has essentially seen linear growth in recent years. Pharmaceutical, CRO, university and healthcare organizations are beginning to shift away from theoretical plans to genuine practical applications of machine intelligence. But what problems are these institutions trying to solve? Dr. Lester Russell, Associate Partner, Clinical Digital Innovation at IBM and a part-time General Practitioner (GP) in the South of England, provides his perspective on the use of Artificial Intelligence within the life sciences industries.